Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer

Yunfeng Ma, Jiru Xu, Yanhong Ji et al.|Oncotarget|2016

Cited by 47